We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.
This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.
|Denali Therapeutics Inc.||F-star Gamma Ltd.||$24 million|
|Zai Lab Limited||Exclusive worldwide license to protein therapeutics||N/A|
|Aquiline Capital Partners||Aspirion Health Resources||N/A|
|Laboratories, MRI and Dialysis|
|Myriad Genetics, Inc.||Counsyl, Inc.||$375 million|
|WellCare Health Plans, Inc.|
|Newsoara Biopharma Co., Ltd.||Exclusive rights to PDE4 inhibitor program in China||N/A|
|Acerus Pharmaceuticals Corporation||Exclusive rights to SHACT||N/A|
|Link Health Group LTD||Exclusive license to Lidoderm in China||N/A|
|Physician Medical Groups|
|Revelstoke Capital Partners||Cincinnati Eye Institute||N/A|
|Linden Capital Partners||Evolution Research Group, LLC||N/A|